SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-06-000064
Filing Date
2006-11-14
Accepted
2006-11-14 17:00:48
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 10Q DOR 3Q 2006 dor3q06.htm 10QSB 421828
2 CEO CERT 302-093006 ceocert302-093006.htm EX-31.1 12686
3 CFO CERT 302 - FOR 3Q-2006 cfocert3023q2006.htm EX-31.2 12675
4 CEO CERT 906 - 3Q-2006 ceocert906-3q2006.htm EX-32.1 6235
5 CFO CERT 906 - 3 Q 2006 cfocert906-3q2006.htm EX-32.2 6224
6 RISK FACTORS 3Q 2006 riskfactors3q2006.htm EX-99.1 87189
  Complete submission text file 0000812796-06-000064.txt   548455
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 061216393
SIC: 2834 Pharmaceutical Preparations